We are live on ! Find out more
SCF

Sante Capital Fund Portfolio holdings

AUM $48.9M
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$108M
AUM Growth
-$134M
Cap. Flow
-$134M
Cap. Flow %
-123.74%
Top 10 Hldgs %
74.67%
Holding
134
New
24
Increased
7
Reduced
2
Closed
101

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$42.4M
2
PANW icon
Palo Alto Networks
PANW
+$5.06M
3
QTWO icon
Q2 Holdings
QTWO
+$4.23M
4
ESTC icon
Elastic
ESTC
+$4.16M
5
FRPT icon
Freshpet
FRPT
+$3.47M

Top Sells

Rank Stock Value
1
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$68.4M
2
AAPL icon
Apple
AAPL
+$12.7M
3
TSLA icon
Tesla
TSLA
+$10.8M
4
SBAC icon
SBA Communications
SBAC
+$6.62M
5
VRT icon
Vertiv
VRT
+$4.31M

Sector Composition

Rank Sector Weight
1 Technology 34.64%
2 Healthcare 10.84%
3 Consumer Staples 3.2%
4 Communication Services 2.95%
5 Energy 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRS
126
DELISTED
Amyris Inc.
AMRS
– –
-76,597
Closed -$1.25M
COUP
127
DELISTED
Coupa Software Incorporated
COUP
– –
-5,163
Closed -$1.35M
SRNE
128
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-80,414
Closed -$779K
VLDR
129
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
– –
-97,567
Closed -$1.04M
PLAN
130
DELISTED
Anaplan, Inc.
PLAN
– –
-22,896
Closed -$1.22M
ZNGA
131
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
– –
-110,910
Closed -$1.18M
ARNA
132
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-41,502
Closed -$2.83M
DRNA
133
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-29,963
Closed -$1.12M
BHVN
134
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-37,671
Closed -$3.66M
2 3 4 5
6

Similar funds

AEPIP
AH Equity Partners IV (Parallel) Menlo Park, California $48.6M AUM 73.24% 1-Year Est. Return
PIPST
Prescott Investors Profit Sharing Trust Boca Raton, Florida $46.4M AUM 47.59% 1-Year Est. Return
MCAI
Meritech Capital Associates IV Palo Alto, California $51.9M AUM 64.09% 1-Year Est. Return
ATGP
Addition Three General Partner New York $45.4M AUM 15.31% 1-Year Est. Return
ER
Enlightenment Research Miami, Florida $45.2M AUM 15.22% 1-Year Est. Return
BI
Blooom Inc Overland Park, Kansas $52.7M AUM 6.26% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
SCM
SCW Capital Management Dallas, Texas $44M AUM 39.16% 1-Year Est. Return

Sante Capital Fund's Q3 2021 Portfolio in Review

As of Q3 2021, Sante Capital Fund held 134 positions worth $108M, down 55% from $242M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Sante Capital Fund withdrew a net $134M in Q3 2021, closing 101 positions and reducing 2 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $68.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Sante Capital Fund opened a new position in Palo Alto Networks worth $5.75M.

  • Sante Capital Fund's largest Q3 2021 buy was Palo Alto Networks: 72,072 shares worth $5.75M.
  • Sante Capital Fund added most to Invesco QQQ Trust in Q3 2021, an estimated $42.4M increase.
  • Sante Capital Fund's biggest Q3 2021 reduction was Allakos, cutting an estimated $2.14M.
  • Sante Capital Fund fully exited ProShares UltraPro QQQ in Q3 2021, selling an estimated $68.4M.
  • Sante Capital Fund's ten largest holdings make up 75% of its $108M portfolio in Q3 2021.
  • Sante Capital Fund opened 24 new positions and closed 101 in Q3 2021.
  • Sante Capital Fund's portfolio value fell 55% quarter-over-quarter to $108M.

Based on Sante Capital Fund's 13F filing for Q3 2021, filed 15 Nov 2021.